 Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
| Descriptor ID |
D023241
|
| MeSH Number(s) |
E02.319.310.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in UAMS Profiles by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 1 | 2 | | 2019 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2015 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2013 | 2 | 2 | 4 | | 2012 | 1 | 0 | 1 | | 2011 | 2 | 1 | 3 | | 2010 | 1 | 1 | 2 | | 2009 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2007 | 1 | 2 | 3 | | 2006 | 0 | 2 | 2 | | 2004 | 1 | 0 | 1 | | 2002 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles over the past ten years.
-
Leffert J, Purushothaman R, Vilanilam GK, Stanley M, Kothari A. HIV-vacuolar myelopathy: an unusual early presentation in HIV. Int J STD AIDS. 2021 02; 32(2):205-208.
-
Callen AL, Dupont SM, Pyne J, Talbott J, Tien P, Calabrese E, Saloner D, Chow FC, Narvid J. The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women. J Neurovirol. 2020 10; 26(5):734-742.
-
Liu J, Shah SK, Basu-Ray I, Garcia-Diaz J, Khalid K, Saeed M. QT prolongation in HIV-positive patients: Review article. Indian Heart J. 2019 Nov - Dec; 71(6):434-439.
-
Pei Q, Han X, Zhang Y, Zhang W, Zhou DB. [Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb; 26(1):146-152.
-
Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4.
-
Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015 Jul 09; 126(2):160-6.
-
Sacktor N, Miyahara S, Evans S, Schifitto G, Cohen B, Haughey N, Drewes JL, Graham D, Zink MC, Anderson C, Nath A, Pardo CA, McCarthy S, Hosey L, Clifford D. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol. 2014 Dec; 20(6):620-6.
-
Dugdale C, Zaller N, Bratberg J, Berk W, Flanigan T. Missed opportunities for HIV screening in pharmacies and retail clinics. J Manag Care Spec Pharm. 2014 Apr; 20(4):339-45.
-
Kaur G, Sharma G, Kumar N, Kaul MH, Bansal RA, Vajpayee M, Wig N, Sharma SK, Mehra NK. Genomic architecture of HIV-1 infection: current status & challenges. Indian J Med Res. 2013 Nov; 138(5):663-81.
-
Atreya AR, Arora S, Gadiraju VT, Martagon-Villamil J, Skiest DJ. Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response. Int J STD AIDS. 2014 Apr; 25(5):383-6.
-
Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, Kaplan LD, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Oriol A, Navarro JT, Dunleavy K, Little RF, Ratner L, Garcia O, Morgades M, Remick SC, Noy A, Sparano JA. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 Nov 07; 122(19):3251-62.
-
Muzaffar J, Usmani S, Abdallah AO, Anaissie E, Cottler-Fox M, Restrepo A. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):171-4.
-
Linguissi LS, Bisseye C, Sagna T, Nagalo BM, Ouermi D, Djigma FW, Pignatelli S, Sia JD, Pietra V, Moret R, Nikiema JB, Simpore J. Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa. Asian Pac J Trop Med. 2012 Dec; 5(12):991-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|